SCJI affects a broad demographic and is associated with various pathogens and significant comorbidities. Early recognition and tailored treatment strategies are critical for improving outcomes. Standardized guidelines and further prospective studies are essential to optimize the management of this rare but serious infection.
Chen et al. (Fri,) studied this question.